British Journal of Haematology, 179(5), 756-771. Wiley-Blackwell Cholujova, D, Bujnakova, Z, Dutkova, E, Hideshima, T, Groen, R W, Mitsiades, C S, Richardson, P G, Dorfman, D M, Balaz, P, Anderson, K C & Jakubikova, J 2017, ' Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma ', British Journal of Haematology, vol. 179, no. 5, pp. 756-771 . https://doi.org/10.1111/bjh.14974